DORAL, Florida, March 07, 2019 (GLOBE NEWSWIRE)
-- Earth Science Tech, Inc. (ETST) (“ETSTâ€
or the “Companyâ€), an innovative biotech company focused on the
cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical
devices, and research and development, announces that it has
engaged Derek Lindsay as a consultant to manage compliance for the
potential dual listing of the Company’s common shares on the
Canadian Securities Exchange (the “CSEâ€) in addition to its current
listing on the OTCQB.
Derek Lindsay assist ETST with the listing process on the CSE as previously announced by the Company and will implement an investor relation program and other items.
“Dual listing is a major achievement and one that can provide ETST access to new investors and capital,†stated Mr. Lindsay. “Considering that ETST’s R&D division is based in Canada, cross-listing appears well-aligned with the corporate vision. Once this milestone is complete, ongoing efforts will be needed to monitor and ensure compliance, build shareholder value, and communicate with investors. I look forward to supporting the Company in these endeavors.â€
Derek Lindsay has solid experience in accelerating the growth of emerging private and public companies, serving as in various capacities that include investor, member of the management team or on the board of directors. His expertise includes capital raising, strategic advice, investor relations and risk management.
ETST President and Chairman Nickolas Tabraue, stated, “We believe Derek’s expertise makes him the perfect fit to ensure that we improve communication with our shareholders and progress on the CSE listing. I plan on sharing further updates as we advance this initiative.â€
About Earth Science Tech, Inc.
(ETST)
Earth Science Tech, Inc. (“ETSTâ€) offers the highest purity and
quality high-grade full spectrum cannabinoid oil on the market.
There are positive results in studies on breast cancer and immune
cells through the University of Central Oklahoma, in addition to
studies through DV Biologics that prove the Company’s CBD oil
formulation lowers cortisol and functions as a neuro-protectant,
with positive result case studies through key health organizations.
ETST formulates, markets and distributes the CBD oil used for its
studies to the public, offering the most effective quality of CBD
on the market.
To learn more, please visit: www.EarthScienceTech.com
ETST currently has two wholly-owned subsidiaries and favored entity focused on developing its role as a world leader in the CBD space, expanding its work in the pharmaceutical and medical device sectors:
Earth Science Pharmaceutical,
Inc.
Earth Science Pharmaceutical ("ESP") is a wholly-owned subsidiary
of Earth Science Tech, committed to the development of low cost,
non-invasive diagnostic tools, medical devices, testing processes
and vaccines for sexually transmitted infections and/or diseases.
ESP's CEO and chief science officer, Dr. Michel Aubé, is
leading the Company’s research and development efforts. The
Company’s first medical device, Hygee™, is a home kit designed for
the detection of STIs, such as chlamydia, from a self-obtained
gynecological specimen. ESP is working to develop and bring to
market medical devices and vaccines that meet the specific needs of
women. To learn more please visit: www.EarthSciencePharmaceutical.com
Cannabis Therapeutics,
Inc.
Cannabis Therapeutics (“CTIâ€) is a wholly-owned subsidiary of Earth
Science Tech, Inc. poised to take a leadership role in the
development of new, leading-edge cannabinoid-based pharmaceutical
and nutraceutical products. CTI is invested in research and
development to explore and harness the medicinal power of
cannabidiol. The company holds three provisional application
patents for a CBD product that is focused on developing treatments
for breast and ovarian cancers, as well as two generic CBD based
pharmaceutical drugs. To learn more please visit: www.CannabisThera.com
Earth Science Foundation,
Inc.
Earth Science Foundation (“ESFâ€) is a favored entity of Earth
Science Tech, Inc. ESF is in the process of becoming a non-profit
organization to accept grants and donations to conduct further
studies and help donate Earth Science Tech's effective CBD products
to those in need. To learn more please visit:
www.ETSTFoundtion.org
SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, listing on the CSE, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
Company Contact:
www.EarthScienceTech.com
Nickolas S. Tabraue
President, Director & Chairman
305.615.2118 Office
Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]